(CCEP) Coca-Cola European Partners - Ratings and Ratios

Exchange: NASDAQ • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: GB00BDCPN049

SoftDrinks, EnergyDrinks, Juices, Tea, Coffee, Water

CCEP EPS (Earnings per Share)

EPS (Earnings per Share) of CCEP over the last years for every Quarter: "2020-03": 0.13785557986871, "2020-06": 0.27038902844639, "2020-09": 0.40879120879121, "2020-12": 0.78752943791927, "2021-03": 0.54254300875274, "2021-06": 0.54254300875274, "2021-09": 0.8074398249453, "2021-12": 1.6516784880599, "2022-03": 0.72816593886463, "2022-06": 1.5178735873362, "2022-09": 0.91812227074236, "2022-12": 1.8362445414847, "2023-03": 0.93028322440087, "2023-06": 1.8605664488017, "2023-09": 0, "2023-12": 1.7717391304348, "2024-03": 1.9, "2024-06": 1.7326086956522, "2024-09": 0, "2024-12": 1.3441558441558, "2025-03": 0, "2025-06": 2.02,

CCEP Revenue

Revenue of CCEP over the last years for every Quarter: 2020-03: 2418.5, 2020-06: 4743.630044, 2020-09: 2884.5, 2020-12: 5565.029802, 2021-03: 6013.613434, 2021-06: 6013.613434, 2021-09: 3922.5, 2021-12: 8010.335348, 2022-03: 4140, 2022-06: 8629.896451, 2022-09: 4520, 2022-12: 9040, 2023-03: 4488.5, 2023-06: 8977, 2023-09: null, 2023-12: 9325, 2024-03: null, 2024-06: 9828, 2024-09: null, 2024-12: 10610, 2025-03: null, 2025-06: null,

Description: CCEP Coca-Cola European Partners

Coca-Cola European Partners PLC (CCEP) is a leading beverage company that produces, distributes, and sells a diverse portfolio of non-alcoholic ready-to-drink beverages across various brands, including iconic names like Coca-Cola, Sprite, Fanta, and Monster Energy. The companys extensive brand portfolio also includes flavors, mixers, energy drinks, soft drinks, water, tea, coffee, and juices.

From a business perspective, CCEPs operations are characterized by a strong presence in the European market, with a wide distribution network and a diverse product offering that caters to different consumer preferences. The companys ability to leverage the Coca-Cola brand, along with its other popular brands, is a significant competitive advantage. Key Performance Indicators (KPIs) that may be relevant to evaluating CCEPs performance include revenue growth, gross margin, operating margin, and return on equity (RoE), which is currently at 37.70%. Other relevant metrics could include volume growth, pricing power, and market share.

In terms of valuation, CCEPs price-to-earnings (P/E) ratio is 26.44, with a forward P/E of 20.62, indicating a relatively high valuation compared to its current earnings. However, the companys strong brand portfolio, diversified revenue streams, and robust operational performance may justify this premium. To further assess the companys attractiveness, investors may want to examine its dividend yield, payout ratio, and cash flow generation capabilities. A thorough analysis of these metrics can provide insights into CCEPs ability to sustain its dividend payments and invest in growth initiatives.

From a technical analysis perspective, CCEPs stock price has shown a strong uptrend, with the current price at $95.45, above its 20-day and 50-day simple moving averages (SMA20 and SMA50). The stocks relative strength index (RSI) and other technical indicators may provide additional insights into its short-term price dynamics. Investors may also want to monitor the companys support and resistance levels, which are critical in determining its price movements.

CCEP Stock Overview

Market Cap in USD 41,250m
Sub-Industry Soft Drinks & Non-alcoholic Beverages
IPO / Inception 1987-01-01

CCEP Stock Ratings

Growth Rating 85.3%
Fundamental 84.2%
Dividend Rating 56.5%
Return 12m vs S&P 500 -2.40%
Analyst Rating 4.0 of 5

CCEP Dividends

Dividend Yield 12m 2.60%
Yield on Cost 5y 6.38%
Annual Growth 5y 16.40%
Payout Consistency 97.0%
Payout Ratio 66.5%

CCEP Growth Ratios

Growth Correlation 3m -12.2%
Growth Correlation 12m 86.9%
Growth Correlation 5y 90.6%
CAGR 5y 20.50%
CAGR/Max DD 5y 0.69
Sharpe Ratio 12m 0.98
Alpha 2.84
Beta 0.543
Volatility 28.77%
Current Volume 1581.8k
Average Volume 20d 1751.7k
Stop Loss 86.1 (-3.1%)
Signal -0.81

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (3.09b TTM) > 0 and > 6% of Revenue (6% = 2.32b TTM)
FCFTA 0.14 (>2.0%) and ΔFCFTA 8.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -3.90% (prev -4.90%; Δ 1.00pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.19 (>3.0%) and CFO 5.87b > Net Income 3.09b (YES >=105%, WARN >=100%)
Net Debt (9.77b) to EBITDA (6.12b) ratio: 1.60 <= 3.0 (WARN <= 3.5)
Current Ratio 0.81 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (462.0m) change vs 12m ago 0.65% (target <= -2.0% for YES)
Gross Margin 36.16% (prev 35.85%; Δ 0.31pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 127.2% (prev 89.54%; Δ 37.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 13.34 (EBITDA TTM 6.12b / Interest Expense TTM 330.2m) >= 6 (WARN >= 3)

Altman Z'' 1.96

(A) -0.05 = (Total Current Assets 6.64b - Total Current Liabilities 8.15b) / Total Assets 31.10b
(B) 0.28 = Retained Earnings (Balance) 8.80b / Total Assets 31.10b
(C) 0.14 = EBIT TTM 4.40b / Avg Total Assets 30.45b
(D) 0.37 = Book Value of Equity 8.18b / Total Liabilities 22.11b
Total Rating: 1.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 84.19

1. Piotroski 6.50pt = 1.50
2. FCF Yield 9.90% = 4.95
3. FCF Margin 11.37% = 2.84
4. Debt/Equity 1.27 = 1.75
5. Debt/Ebitda 1.76 = 0.46
6. ROIC - WACC 10.79% = 12.50
7. RoE 37.70% = 2.50
8. Rev. Trend 60.51% = 3.03
9. Rev. CAGR 22.93% = 2.50
10. EPS Trend -13.53% = -0.34
11. EPS CAGR 33.21% = 2.50

What is the price of CCEP shares?

As of August 31, 2025, the stock is trading at USD 88.86 with a total of 1,581,792 shares traded.
Over the past week, the price has changed by -1.64%, over one month by -10.47%, over three months by -1.97% and over the past year by +14.17%.

Is Coca-Cola European Partners a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, Coca-Cola European Partners (NASDAQ:CCEP) is currently (August 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 84.19 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CCEP is around 97.67 USD . This means that CCEP is currently overvalued and has a potential downside of 9.91%.

Is CCEP a buy, sell or hold?

Coca-Cola European Partners has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CCEP.
  • Strong Buy: 7
  • Buy: 2
  • Hold: 4
  • Sell: 0
  • Strong Sell: 1

What are the forecasts/targets for the CCEP price?

Issuer Target Up/Down from current
Wallstreet Target Price 96.4 8.5%
Analysts Target Price 92.2 3.8%
ValueRay Target Price 106.8 20.2%

Last update: 2025-08-20 02:49

CCEP Fundamental Data Overview

Market Cap EUR = 35.41b (41.25b USD * 0.8584 USD.EUR)
CCE Cash And Equivalents = 1.71b EUR (Cash And Short Term Investments, last quarter)
P/E Trailing = 22.9616
P/E Forward = 19.305
P/S = 1.9752
P/B = 4.3494
P/EG = 1.5957
Beta = 0.622
Revenue TTM = 38.74b EUR
EBIT TTM = 4.40b EUR
EBITDA TTM = 6.12b EUR
Long Term Debt = 9.39b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.39b EUR (from shortTermDebt, last quarter)
Debt = 10.78b EUR (Calculated: Short Term 1.39b + Long Term 9.39b)
Net Debt = 9.77b EUR (from netDebt column, last quarter)
Enterprise Value = 44.48b EUR (35.41b + Debt 10.78b - CCE 1.71b)
Interest Coverage Ratio = 13.34 (Ebit TTM 4.40b / Interest Expense TTM 330.2m)
FCF Yield = 9.90% (FCF TTM 4.40b / Enterprise Value 44.48b)
FCF Margin = 11.37% (FCF TTM 4.40b / Revenue TTM 38.74b)
Net Margin = 7.97% (Net Income TTM 3.09b / Revenue TTM 38.74b)
Gross Margin = 36.16% ((Revenue TTM 38.74b - Cost of Revenue TTM 24.73b) / Revenue TTM)
Tobins Q-Ratio = 5.44 (Enterprise Value 44.48b / Book Value Of Equity 8.18b)
Interest Expense / Debt = 1.21% (Interest Expense 130.2m / Debt 10.78b)
Taxrate = 25.41% (from yearly Income Tax Expense: 492.0m / 1.94b)
NOPAT = 3.29b (EBIT 4.40b * (1 - 25.41%))
Current Ratio = 0.81 (Total Current Assets 6.64b / Total Current Liabilities 8.15b)
Debt / Equity = 1.27 (Debt 10.78b / last Quarter total Stockholder Equity 8.49b)
Debt / EBITDA = 1.76 (Net Debt 9.77b / EBITDA 6.12b)
Debt / FCF = 2.45 (Debt 10.78b / FCF TTM 4.40b)
Total Stockholder Equity = 8.19b (last 4 quarters mean)
RoA = 9.93% (Net Income 3.09b, Total Assets 31.10b )
RoE = 37.70% (Net Income TTM 3.09b / Total Stockholder Equity 8.19b)
RoCE = 25.05% (Ebit 4.40b / (Equity 8.19b + L.T.Debt 9.39b))
RoIC = 17.15% (NOPAT 3.29b / Invested Capital 19.16b)
WACC = 6.36% (E(35.41b)/V(46.19b) * Re(8.02%)) + (D(10.78b)/V(46.19b) * Rd(1.21%) * (1-Tc(0.25)))
Shares Correlation 5-Years: 100.0 | Cagr: 0.35%
Discount Rate = 8.02% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 80.78% ; FCFE base≈3.29b ; Y1≈3.88b ; Y5≈5.93b
Fair Price DCF = 223.5 (DCF Value 101.74b / Shares Outstanding 455.2m; 5y FCF grow 18.87% → 3.0% )
Revenue Correlation: 60.51 | Revenue CAGR: 22.93%
Rev Growth-of-Growth: 21.73
EPS Correlation: -13.53 | EPS CAGR: 33.21%
EPS Growth-of-Growth: 22.45

Additional Sources for CCEP Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle